A Global Phase 3 Double-Blind Placebo-Controlled Safety and Efficacy Study of Oral Dimebon [dimebolin] in Patients With Mild-to-Moderate Alzheimer's Disease (CONNECTION).

Trial Profile

A Global Phase 3 Double-Blind Placebo-Controlled Safety and Efficacy Study of Oral Dimebon [dimebolin] in Patients With Mild-to-Moderate Alzheimer's Disease (CONNECTION).

Completed
Phase of Trial: Phase III

Latest Information Update: 03 Oct 2016

At a glance

  • Drugs Latrepirdine (Primary)
  • Indications Alzheimer's disease
  • Focus Pharmacogenomic; Registrational; Therapeutic Use
  • Acronyms CONNECTION
  • Most Recent Events

    • 16 Nov 2011 Additional locations added as reported by European Clinical Trials Database (EudraCT2008-000095-25).
    • 14 Jul 2010 Results will be presented at the 2010 International Conference on Alzheimer's Disease (ICAD 2010).
    • 14 Jul 2010 Trial design details were presented at the 2010 International Conference on Alzheimer's Disease (ICAD 2010).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top